App-Quantinova.ai

Role of Non-Esterified Fatty Acid in the Hyperandrogenemia of a Rat Model of Polycystic Ovary Syndrome

Christophe Noll - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Polycystic Ovary Syndrome

Angiotensin II

Ciprofloxacin and rifampin have opposite effects on levothyroxine absorption

Rommel Tirona - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

Ciprofloxacin

Do papillary thyroid cancer patients using a computerized decision aid perceive themselves to be better informed about radioactive iodine treatment choice?

Asima Naeem - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Papillary carcinoma

N/A

Lower socioeconomic status is associated with more advanced thyroid cancer stage at presentation: a study in two Canadian centres

Ted McDonald - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Thyroid Cancer

N/A

Differentiated Thyroid Cancer - Clinical Presentation as a Prognostic Variable

Adam S White - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Papillary carcinoma

N/A

Naturally Occurring Variants of Human Corticosteroid-Binding Globulin

Lesley Hill - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

Glucocorticoid

Osteomalacia Associated with Primary Biliary Cirrhosis and Response to Cholecalciferol Therapy: A Case Report

David Edward Harris - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Secondary hyperparathyroidism

cholecalciferol

Serum 25-hydroxyvitamin D is independently associated with peripheral insulin sensitivity, visceral adiposity and adiponectin concentrations in postmenopausal women with abnormal glucose tolerance

Anne-Sophie Morisset - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

N/A

Progesterone metabolites regulate induction, growth and suppression of ER/PR-negative human breast cell tumors

John P Wiebe - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Safety and Testosterone-Lowering Effects of the Investigational, Oral, GnRH Antagonist, TAK-385 in Healthy Male Volunteers: Results of a Phase 1 Inpatient/Outpatient Study

Hongliang Shi - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Male Sexual Dysfunction

Androgen Tear

Comparative Treatment Outcomes In Patients With Prior Fracture Previously Treated With A Bisphosphonate: Results From The Denosumab/Ibandronate and Denosumab/Risedronate Trials

Christian Roux - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoporosis

Ibandronic acid

Utility of N-of-1 trials in the Assessment and Management of Patients with Statin-related Myopathy

Jeffrey L Mahon - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cap myopathy

N/A

Acute Esophageal Necrosis Leading to Esophageal Stricture: A Rare Complication of Diabetic Ketoacidosis in a 12-Year-Old Girl

Alice J Foster - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Diabetic ketoacidosis

N/A

Absence of the ROS Scavenger DJ-1 Paradoxically Protects Mice from Obesity and Insulin Resistance

Shun-Yan Lu - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Parkinson's disease

Cysteine Hydrochloride

Insulin Pump Use in Pregnancy is Associated with Better Glycemic Control Without Increasing the Rate of Severe Hypoglycemia or Diabetic Ketoacidosis in Women with Type 1 Diabetes

Jason M Kong - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Pregnancy-Induced Hypertension

N/A

IGF-I overexpression stimulates CCN5/WISP2 expression in pancreatic a-cells, which promotes cell proliferation and survival against streptozotocin

Xiao Wang - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Type 1 diabetes mellitus

Streptozotocin

Rb deletion in pancreatic progenitors leads to a dichotomous effect in pancreatic ? and ?-cell fate

Xiaohong Wu - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Retinoblastoma

N/A

Alternative Splicing of the Human Growth Hormone Receptor Gene in Normal and Disease States

Christopher Pagano - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

Human growth hormone

Mitochondrial Respiratory Functions Uncouple Prolifeative Signaling from Hormone Secretion in Response to Somatostatin Analogs

Tae Tateno - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Tuberculosis

hGH

Adipocyte-specific FAK deletion in mice leads to insulin resistance but divergent adipose tissue remodelling under lean and obese conditions

Sally Yu Shi - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Tuberculosis

L-Tyrosine

Filters

28841 Abstracts